QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)

Corbus Pharmaceuticals (CRBP) News Today

$36.32
+1.32 (+3.77%)
(As of 03/4/2024 ET)
SourceHeadline
marketbeat.com logoCorbus Pharmaceuticals (CRBP) Scheduled to Post Quarterly Earnings on Tuesday
marketbeat.com - March 4 at 7:23 AM
MarketBeat logoCorbus Pharmaceuticals (NASDAQ:CRBP) Rating Increased to Hold at StockNews.com
americanbankingnews.com - March 1 at 3:42 AM
markets.businessinsider.com logoCorbus Pharmaceuticals Names Dominic Smethurst CMO
markets.businessinsider.com - February 28 at 4:39 PM
globenewswire.com logoCorbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer
globenewswire.com - February 28 at 8:00 AM
MarketBeat logoCorbus Pharmaceuticals (NASDAQ:CRBP) Share Price Passes Above Fifty Day Moving Average of $14.77
americanbankingnews.com - February 28 at 4:58 AM
marketbeat.com logoCorbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Passes Above 50 Day Moving Average of $14.77
marketbeat.com - February 28 at 4:55 AM
finance.yahoo.com logoCorbus Pharmaceuticals Holdings Inc (3371.MU)
finance.yahoo.com - February 25 at 3:47 PM
finance.yahoo.com logoACAD Mar 2024 35.000 put
finance.yahoo.com - February 18 at 3:28 PM
finance.yahoo.com logoACAD Mar 2024 36.000 call
finance.yahoo.com - February 17 at 12:24 AM
marketbeat.com logoShort Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Rises By 1,553.7%
marketbeat.com - February 12 at 9:57 AM
msn.com logoCorbus Pharmaceuticals Announces Chief Scientific Officer Resignation
msn.com - February 7 at 9:38 AM
finance.yahoo.com logoCorbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
finance.yahoo.com - February 6 at 2:06 PM
msn.com logoCorbus Pharmaceuticals Shares Updated Corporate Insights
msn.com - February 6 at 9:06 AM
marketbeat.com logoCorbus Pharmaceuticals stock: An explosive 342% YTD surge
marketbeat.com - February 5 at 8:40 AM
morningstar.com logoCorbus Pharmaceuticals Holdings Inc
morningstar.com - February 3 at 3:40 PM
finance.yahoo.com logoCorbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - February 2 at 6:20 PM
msn.com logoCorbus Pharmaceuticals Strikes Deal for Public Stock Offering
msn.com - February 2 at 1:19 PM
benzinga.com logoCorbus Pharmaceuticals Stock (NASDAQ:CRBP), Analyst Ratings, Price Targets, Predictions
benzinga.com - February 1 at 1:01 PM
msn.com logoWhat's Going On With Cancer-Focused Corbus Pharmaceuticals Stock Today?
msn.com - February 1 at 1:01 PM
finance.yahoo.com logoRetail investors in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) are its biggest bettors, and their bets paid off as stock gained 214% last week
finance.yahoo.com - February 1 at 8:01 AM
msn.com logo$16.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
msn.com - January 31 at 3:40 PM
msn.com logoWhy Corbus Pharmaceuticals Shares Are Gaining Today
msn.com - January 31 at 10:40 AM
markets.businessinsider.com logoCorbus Pharmaceutical Prices Offering Of Approx. 4.3 Mln Shares At $19 Per Share; Stock Up
markets.businessinsider.com - January 31 at 10:40 AM
finance.yahoo.com logoCorbus Pharmaceuticals Announces Pricing of Public Offering
finance.yahoo.com - January 31 at 10:40 AM
markets.businessinsider.com logoCorbus Pharma Announces Proposed Public Offering; Stock Surges
markets.businessinsider.com - January 31 at 12:28 AM
investing.com logoCorbus Pharmaceuticals Holding (CRBP)
investing.com - January 30 at 7:28 PM
finance.yahoo.com logoCorbus Pharmaceuticals Announces Proposed Public Offering
finance.yahoo.com - January 30 at 7:28 PM
msn.com logoCorbus Pharmaceuticals Raises $16.8 Million from Stock Sale
msn.com - January 30 at 2:27 PM
seekingalpha.com logoCorbus Pharmaceuticals: Surging On The Back Of Great News, But I See Dark Clouds
seekingalpha.com - January 29 at 7:12 PM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Biogen (BIIB), Corbus Pharmaceuticals (CRBP)
markets.businessinsider.com - January 29 at 2:11 PM
seekingalpha.com logoCorbus Pharma reverses gains on common stock offering
seekingalpha.com - January 29 at 9:10 AM
finance.yahoo.com logoInvestors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate
finance.yahoo.com - January 29 at 9:10 AM
nasdaq.com logoCorbus Pharma Spikes 256% On Positive Results For CRB-701 In First Human Study
nasdaq.com - January 28 at 3:46 AM
msn.com logoWhy Is Precision Oncology-Focused Corbus Pharmaceuticals Stock Trading Higher Today?
msn.com - January 27 at 3:44 AM
finance.yahoo.com logoCRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024
finance.yahoo.com - January 27 at 3:44 AM
investorplace.com logoWhy Is Corbus Pharmaceuticals (CRBP) Stock Up 300% Today?
investorplace.com - January 26 at 3:53 PM
marketbeat.com logo
marketbeat.com - January 26 at 12:20 PM
marketbeat.com logo
marketbeat.com - January 26 at 10:29 AM
marketbeat.com logo
marketbeat.com - January 26 at 10:19 AM
marketbeat.com logo
marketbeat.com - January 26 at 10:07 AM
marketbeat.com logo
marketbeat.com - January 26 at 10:01 AM
marketbeat.com logo
marketbeat.com - January 26 at 9:42 AM
finance.yahoo.com logoPhase 1 Clinical Data for SYS6002 (CRB-701) to be presented at 2024 ASCO GU
finance.yahoo.com - January 23 at 8:09 AM
morningstar.com logoCorbus Pharmaceuticals Holdings Inc CRBP
morningstar.com - January 12 at 7:10 PM
nasdaq.com logoCorbus Pharma's IND Application Gets FDA Clearance For Anti-avß8 Monoclonal Antibody CRB-601
nasdaq.com - January 9 at 1:47 PM
finance.yahoo.com logoCorbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-αvβ8 monoclonal antibody (CRB-601)
finance.yahoo.com - January 9 at 8:47 AM
benzinga.com logoCorbus Pharmaceuticals Stock (NASDAQ:CRBP) Dividends: History, Yield and Dates
benzinga.com - January 3 at 10:21 PM
finance.yahoo.com logoCorbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO GU
finance.yahoo.com - December 18 at 12:47 PM
marketbeat.com logo
marketbeat.com - December 8 at 9:56 AM
finance.yahoo.com logoIs Corbus Pharmaceuticals (CRBP) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - December 1 at 12:41 PM
Get Corbus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter.



CRBP Media Mentions By Week

CRBP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRBP
News Sentiment

0.60

0.65

Average
Medical
News Sentiment

CRBP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRBP Articles
This Week

9

1

CRBP Articles
Average Week

Get Corbus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CRBP) was last updated on 3/4/2024 by MarketBeat.com Staff